Article

Case series: Combined spinal epidural anesthesia for Cesarean delivery and ex utero intrapartum treatment procedure.

Department of Anesthesiology, Women's Anesthesia and Critical Care, Box 3094, Duke University Medical Center, Durham, NC 27710, USA.
Canadian Journal of Anaesthesia (Impact Factor: 2.5). 04/2007; 54(3):218-22. DOI: 10.1007/BF03022643
Source: PubMed

ABSTRACT To report the use of regional anesthesia and iv nitroglycerin to provide anesthesia and uterine relaxation for three Cesarean deliveries (CD) involving ex utero intrapartum treatment (EXIT) of potentially life-threatening airway obstruction in the newborn.
Case 1--a 36-yr-old woman at 38 weeks' gestation was scheduled for an elective CD for fetal skeletal dysplasia and micrognathia. Case 2--a 34-yr-old woman at 35 weeks gestation had a fetal ultrasound revealing fixed neck flexion and micrognathia consistent with fetal arthrogryposis. Case 3--a 27-yr-old woman presented at 38 weeks gestation for CD for severe fetal micrognathia, with mandibular growth below the fifth percentile. For each case, a combined spinal epidural anesthetic was performed with 0.75% bupivacaine, fentanyl and morphine intrathecally followed by placement of a multiorifice epidural catheter. Prior to uterine incision patients received a loading dose followed by an iv infusion of nitroglycerin. Uterine relaxation was sufficient in all cases for delivery of the fetus, and allowed for evaluation by direct laryngoscopy and intubation while maintaining fetal-placental circulation. The surgical procedures were completed without incident.
Anesthesia and uterine relaxation for CD and EXIT procedures can be safely provided with regional anesthesia and iv nitroglycerin.

0 Followers
 · 
111 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the present study is to substantiate and compare the quality and extent of nerve block by using intrathecal bupivacaine or extradural bupivacaine alone and in combined spinal-epidural (CSE) technique using smaller dose of intrathecal bupivacaine and extradural injection of a smaller dose of bupivacaine or normal saline. A prospective study design was set up with 60 adult patients scheduled for vaginal and lower abdominal operation under CSE technique and single spinal or epidural technique. 60 patients undergoing infra-umbilical surgery were divided into three groups (Group). Group A1 (control) 10 patients received 3 ml of intrathecal heavy bupivacaine. A2-10 patients received 16 ml isobaric bupivacaine extradurally Group B (n = 20) patients received 2 ml intrathecal heavy bupivacaine and 10 ml normal saline extradurally. Group C patients (n = 20) received 2 ml heavy bupivacaine intrathecally and 10 ml isobaric bupivacaine extradurally. A total duration of this study was 18 months. Duration of motor block, sensory block, analgesia, onset of sensory block and cephaloid extent of sensory block and side-effects noted among patients. Visual analog scale in the post-operative period was recorded. The results were analyzed statistically by applying analysis of variable, odds ratio and Chi-square test. Patients were comparable regarding the onset time and height and duration of sensory block with a significant difference, though there was no difference in duration of motor block and analgesia. The side-effects in the control group are higher than the other two groups. Quality of nerve block in combined technique using bupivacaine both intrathecally and extradurally is better and associated with lower side-effect compared with intrathecal heavy bupivacaine or extradural isobaric bupivacaine alone.
    11/2013; 8(1):54-58. DOI:10.4103/0259-1162.128909
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction. Normal pregnancy is characterized by a controlled inflammatory state, localized at the level of the implant area during early stages, and generalized in the last trimester of pregnancy. Preeclampsia represents an exacerbation of systemic inflammatory response. Aim. Evaluation of IL-6 in the serum of preeclamptic pregnant women in the last trimester of pregnancy compared to normal pregnancy. Investigation of a possible relationship between the intensity of the inflammatory syndrome, the severity of preeclampsia, and fetal status at birth. Material and method. A transversal study was performed in three groups of patients: group 1 (preeclampsia); group 2 (normal pregnancy); group 3 (control). The serum samples for the determination of IL-6 were processed using the HS human IL-6 Elisa kit. Results. A significant positive correlation between serum IL-6 concentration and blood pressure values was found. A significant positive correlation was also obtained in preeclampsia between serum IL-6 concentration and uric acid concentration, as well as proteinuria. A significant negative correlation between serum IL-6 concentration, fetal weight at birth and the Apgar score of the newborn was found. Conclusions. Serum IL-6 concentration represents a marker of the severity of preeclamptic syndrome, being at the same time an accuracy predictor of fetal weight and status at birth.
    Gineco.ro 01/2010; · 0.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The scope of obstetric anesthesia practice ranges far beyond the delivery of care to women for vaginal and cesarean deliveries. Increasingly, obstetric anesthesiologists are involved in the management of anesthetics for new procedures and for new indications. Anesthesia is frequently needed for maternal procedures, as well as fetal procedures, and at varying times in the intrapartum period. Maternal-specific procedures include cerclage, external cephalic version (ECV), postpartum bilateral tubal ligation (BTL), and dilation and evacuation (D and E). Fetus-specific procedures include fetoscopic laser photocoagulation and ex-utero intrapartum treatment (EXIT). This review will not include discussion of the anesthetic management of non-obstetric surgery during pregnancy, such as appendectomy or cholecystectomy.
    Seminars in Perinatology 10/2014; 38(6). DOI:10.1053/j.semperi.2014.07.005 · 2.42 Impact Factor